vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and SMARTFINANCIAL INC. (SMBK). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $53.8M, roughly 1.2× SMARTFINANCIAL INC.). SMARTFINANCIAL INC. runs the higher net margin — 25.4% vs -70.9%, a 96.3% gap on every dollar of revenue. Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 15.4%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
SmartFinancial Inc. is a U.S.-based bank holding company that operates its wholly owned subsidiary SmartBank. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, mortgage services, and wealth management solutions, primarily serving individual customers and small-to-medium enterprises across the Southeastern United States.
CTKB vs SMBK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $53.8M |
| Net Profit | $-44.1M | $13.7M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 25.4% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -557.1% | 21.6% |
| EPS (diluted) | — | $0.81 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $53.8M | ||
| Q4 25 | $62.1M | $53.3M | ||
| Q3 25 | $52.3M | $51.1M | ||
| Q2 25 | $45.6M | $49.2M | ||
| Q1 25 | $41.5M | $46.8M | ||
| Q4 24 | $57.5M | $46.8M | ||
| Q3 24 | $51.5M | $44.2M | ||
| Q2 24 | $46.6M | $40.4M |
| Q1 26 | — | $13.7M | ||
| Q4 25 | $-44.1M | $13.7M | ||
| Q3 25 | $-5.5M | $13.7M | ||
| Q2 25 | $-5.6M | $11.7M | ||
| Q1 25 | $-11.4M | $11.3M | ||
| Q4 24 | $9.6M | $9.6M | ||
| Q3 24 | $941.0K | $9.1M | ||
| Q2 24 | $-10.4M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 31.3% | ||
| Q3 25 | -17.6% | 33.2% | ||
| Q2 25 | -23.3% | 29.0% | ||
| Q1 25 | -36.1% | 29.0% | ||
| Q4 24 | 5.2% | 26.5% | ||
| Q3 24 | -8.2% | 24.3% | ||
| Q2 24 | -18.3% | 25.6% |
| Q1 26 | — | 25.4% | ||
| Q4 25 | -70.9% | 25.7% | ||
| Q3 25 | -10.5% | 26.8% | ||
| Q2 25 | -12.2% | 23.8% | ||
| Q1 25 | -27.5% | 24.0% | ||
| Q4 24 | 16.8% | 20.6% | ||
| Q3 24 | 1.8% | 20.7% | ||
| Q2 24 | -22.4% | 19.8% |
| Q1 26 | — | $0.81 | ||
| Q4 25 | — | $0.81 | ||
| Q3 25 | — | $0.81 | ||
| Q2 25 | — | $0.69 | ||
| Q1 25 | — | $0.67 | ||
| Q4 24 | — | $0.57 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | — | $0.48 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $346.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $562.2M |
| Total Assets | $461.5M | $5.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $346.1M | ||
| Q4 25 | $90.9M | $464.4M | ||
| Q3 25 | $93.3M | $557.1M | ||
| Q2 25 | $75.5M | $365.1M | ||
| Q1 25 | $95.3M | $423.0M | ||
| Q4 24 | $98.7M | $387.6M | ||
| Q3 24 | $162.3M | $192.9M | ||
| Q2 24 | $177.9M | $342.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.3M | ||
| Q2 25 | — | $7.0M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $8.1M | ||
| Q3 24 | — | $9.0M | ||
| Q2 24 | — | $12.7M |
| Q1 26 | — | $562.2M | ||
| Q4 25 | $341.7M | $552.4M | ||
| Q3 25 | $378.6M | $538.4M | ||
| Q2 25 | $377.6M | $519.0M | ||
| Q1 25 | $379.6M | $505.8M | ||
| Q4 24 | $395.7M | $491.3M | ||
| Q3 24 | $385.5M | $489.0M | ||
| Q2 24 | $389.1M | $472.5M |
| Q1 26 | — | $5.9B | ||
| Q4 25 | $461.5M | $5.9B | ||
| Q3 25 | $494.9M | $5.8B | ||
| Q2 25 | $493.3M | $5.5B | ||
| Q1 25 | $482.6M | $5.4B | ||
| Q4 24 | $499.5M | $5.3B | ||
| Q3 24 | $491.2M | $4.9B | ||
| Q2 24 | $483.7M | $4.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $61.7M | ||
| Q3 25 | $-3.9M | $16.9M | ||
| Q2 25 | $108.0K | $14.0M | ||
| Q1 25 | $-125.0K | $14.3M | ||
| Q4 24 | $2.0M | $52.7M | ||
| Q3 24 | $13.2M | $12.4M | ||
| Q2 24 | $6.2M | $16.5M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | $59.3M | ||
| Q3 25 | $-4.6M | $16.6M | ||
| Q2 25 | $-1.5M | $13.2M | ||
| Q1 25 | $-974.0K | $13.4M | ||
| Q4 24 | $1.1M | $46.3M | ||
| Q3 24 | $12.2M | $11.3M | ||
| Q2 24 | $5.2M | $15.4M |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | 111.3% | ||
| Q3 25 | -8.7% | 32.4% | ||
| Q2 25 | -3.2% | 26.9% | ||
| Q1 25 | -2.3% | 28.5% | ||
| Q4 24 | 1.9% | 98.9% | ||
| Q3 24 | 23.7% | 25.7% | ||
| Q2 24 | 11.0% | 38.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | 4.5% | ||
| Q3 25 | 1.3% | 0.6% | ||
| Q2 25 | 3.5% | 1.6% | ||
| Q1 25 | 2.0% | 2.0% | ||
| Q4 24 | 1.6% | 13.7% | ||
| Q3 24 | 2.0% | 2.4% | ||
| Q2 24 | 2.3% | 2.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.50× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.20× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | 0.21× | 5.47× | ||
| Q3 24 | 14.05× | 1.36× | ||
| Q2 24 | — | 2.07× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SMBK
| Net Interest Income | $45.9M | 85% |
| Noninterest Income | $7.9M | 15% |
